Aoxing Pharmaceutical Company Inc
Aoxing Pharmaceutical Company, Inc. a specialty pharmaceutical company, engages in research and development, manufacture, and distribution of narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the People's Republic of China. The company's principal products include Zhongtong'an, a capsule of herbal extraction for the indication of oral and dental pain; and Yiq… Read more
Aoxing Pharmaceutical Company Inc (AOXG) - Total Assets
Latest total assets as of March 2017: $62.47 Million USD
Based on the latest financial reports, Aoxing Pharmaceutical Company Inc (AOXG) holds total assets worth $62.47 Million USD as of March 2017.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Aoxing Pharmaceutical Company Inc - Total Assets Trend (2001–2016)
This chart illustrates how Aoxing Pharmaceutical Company Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Aoxing Pharmaceutical Company Inc - Asset Composition Analysis
Current Asset Composition (June 2016)
Aoxing Pharmaceutical Company Inc's total assets of $62.47 Million consist of 47.8% current assets and 52.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 12.3% |
| Accounts Receivable | $11.20 Million | 19.9% |
| Inventory | $2.84 Million | 5.1% |
| Property, Plant & Equipment | $25.60 Million | 45.5% |
| Intangible Assets | $1.88 Million | 3.3% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2001–2016)
This chart illustrates how Aoxing Pharmaceutical Company Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Aoxing Pharmaceutical Company Inc's current assets represent 47.8% of total assets in 2016, an increase from 0.0% in 2001.
- Cash Position: Cash and equivalents constituted 12.3% of total assets in 2016, up from 0.2% in 2001.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, an increase from 0.0% in 2001.
- Asset Diversification: The largest asset category is property, plant & equipment at 45.5% of total assets.
Aoxing Pharmaceutical Company Inc Competitors by Total Assets
Key competitors of Aoxing Pharmaceutical Company Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
464680
KQ:464680
|
Korea | ₩31.23 Billion |
|
Cartesian Growth Corporation III Unit
NASDAQ:CGCTU
|
USA | $281.56 Million |
|
Azure Holding Group Corp
PINK:AZRH
|
USA | $16.92 Million |
|
Constellation Capital Corp.
V:CNST-P
|
Canada | CA$627.53K |
|
Little Fish Acquisition I Corp.
V:LILL-P
|
Canada | CA$56.48K |
|
Hana 30 Special Purpose Acquisition Company
KQ:469880
|
Korea | ₩17.89 Billion |
|
Chicane Capital I Corp.
V:CCIC-P
|
Canada | CA$199.07K |
|
Cuspis Capital II Ltd
V:CCII-P
|
Canada | CA$1.51 Million |
Aoxing Pharmaceutical Company Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Aoxing Pharmaceutical Company Inc generates 0.57x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Aoxing Pharmaceutical Company Inc generates $ 3.67 in net profit.
Aoxing Pharmaceutical Company Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.79 | 0.77 | 0.51 |
| Quick Ratio | 0.74 | 0.67 | 0.41 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-9.17 Million | $ -8.71 Million | $ -9.11 Million |
Aoxing Pharmaceutical Company Inc - Advanced Valuation Insights
This section examines the relationship between Aoxing Pharmaceutical Company Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.07 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 6.0% |
| Total Assets | $56.23 Million |
| Market Capitalization | $369.49K USD |
Valuation Analysis
Below Book Valuation: The market values Aoxing Pharmaceutical Company Inc's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Aoxing Pharmaceutical Company Inc's assets grew by 6.0% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Aoxing Pharmaceutical Company Inc (2001–2016)
The table below shows the annual total assets of Aoxing Pharmaceutical Company Inc from 2001 to 2016.
| Year | Total Assets | Change |
|---|---|---|
| 2016-06-30 | $56.23 Million | +6.02% |
| 2015-06-30 | $53.04 Million | +39.31% |
| 2014-06-30 | $38.07 Million | -4.17% |
| 2013-06-30 | $39.73 Million | -11.88% |
| 2012-06-30 | $45.09 Million | -22.91% |
| 2011-06-30 | $58.49 Million | +0.28% |
| 2010-06-30 | $58.33 Million | +2.79% |
| 2009-06-30 | $56.74 Million | +1.10% |
| 2008-06-30 | $56.13 Million | +82.75% |
| 2007-06-30 | $30.71 Million | +70.82% |
| 2006-06-30 | $17.98 Million | +212.04% |
| 2005-06-30 | $5.76 Million | -12.39% |
| 2003-06-30 | $6.58 Million | -15.43% |
| 2002-06-30 | $7.78 Million | -2.23% |
| 2001-06-30 | $7.95 Million | -- |